SHELLEY FOX: Open Payments
NPI 1255603817 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 31 payments from 12 companies in 2025. Trend: 2023 $1,682 · 2024 $1,299 · 2025 $1,212
Food & beverage: $1,112Education: $100
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 1 | $155 |
| Almirall LLC | 3 | $154 |
| REVANCE THERAPEUTICS, INC. | 1 | $148 |
| Organogenesis Inc. | 8 | $147 |
| Lilly USA, LLC | 2 | $147 |
| Botanix SB Inc | 5 | $137 |
| Solventum Corporation | 4 | $132 |
| Janssen Biotech, Inc. | 1 | $100 |
| PFIZER INC. | 2 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $31 |
Products named: Kerecis SurgiClose, DAXI, SOFDRA, Seysara, ACTIV.A.C., TREMFYA, OLUMIANT, NOVACHOR.
Industry payments across FL — which companies pay providers there.
